Non-neutralizing, serotype-specific anti-NS1 monoclonal antibodies partially protected passively immunized mice from lethal dengue 2 virus intracerebral challenge. There was no apparent correlation between complement-fixing activity and protective capacity among individual anti-NS1 monoclonal ntibodies. Immunization with specific ombinations ofnon-protective or partially protective antibodies resulted in prolonged survival or reduced mortality. Solid protection, equal to that achieved after immunization with neutralizing polyclonal antibody, was achieved only with an antibody pair which individually fixed complement to high titre with homologous virus. Some groups of mice had increased morbidity after immunization with combinations of prote...
Antibody-mediated enhancement of dengue virus repli-cation is thought to be a mechanism contributing...
Dengue viruses (DENV) are the causative agents of dengue fever (DF) and dengue hemorrhagic fever (DH...
ABSTRACT Following natural dengue virus (DENV) infection, humans produce some antibodies that recogn...
Half of the world's population is exposed to the risk of dengue virus infection. Although a vaccine ...
Antibody protection against flaviviruses is associated with the development of neutralizing antibodi...
The mosquito-borne dengue virus (DENV) is endemic in 100 countries and annually threatens over half ...
The flavivirus envelope glycoprotein (E) is responsible for viral attachment and entry by membrane f...
International audienceAntibodies protect against homologous Dengue virus (DENV) infection but can pr...
Antibodies protect against homologous Dengue virus (DENV) infection but can precipitate severe dengu...
Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complications foll...
Abstract. A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a ...
SummaryAntibodies protect against homologous Dengue virus (DENV) infection but can precipitate sever...
Dengue fever and its more severe form, dengue hemorrhagic fever, are major global concerns. Infectio...
Antibodies protect against homologous Dengue virus (DENV) infection but can precipitate severe dengu...
<div><p>Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complicati...
Antibody-mediated enhancement of dengue virus repli-cation is thought to be a mechanism contributing...
Dengue viruses (DENV) are the causative agents of dengue fever (DF) and dengue hemorrhagic fever (DH...
ABSTRACT Following natural dengue virus (DENV) infection, humans produce some antibodies that recogn...
Half of the world's population is exposed to the risk of dengue virus infection. Although a vaccine ...
Antibody protection against flaviviruses is associated with the development of neutralizing antibodi...
The mosquito-borne dengue virus (DENV) is endemic in 100 countries and annually threatens over half ...
The flavivirus envelope glycoprotein (E) is responsible for viral attachment and entry by membrane f...
International audienceAntibodies protect against homologous Dengue virus (DENV) infection but can pr...
Antibodies protect against homologous Dengue virus (DENV) infection but can precipitate severe dengu...
Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complications foll...
Abstract. A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a ...
SummaryAntibodies protect against homologous Dengue virus (DENV) infection but can precipitate sever...
Dengue fever and its more severe form, dengue hemorrhagic fever, are major global concerns. Infectio...
Antibodies protect against homologous Dengue virus (DENV) infection but can precipitate severe dengu...
<div><p>Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complicati...
Antibody-mediated enhancement of dengue virus repli-cation is thought to be a mechanism contributing...
Dengue viruses (DENV) are the causative agents of dengue fever (DF) and dengue hemorrhagic fever (DH...
ABSTRACT Following natural dengue virus (DENV) infection, humans produce some antibodies that recogn...